BioCentury
ARTICLE | Finance

Accelerating investor interest

Why Advanced Accelerator Applications did U.S. crossover round after failed IPO

July 13, 2015 7:00 AM UTC

Advanced Accelerator Applications S.A. hopes that a trio of U.S. crossover investors will help the nuclear medicine play garner a better valuation if it takes another shot at tapping the U.S. IPO market.

On June 23, Advanced Accelerator raised €23 million ($26 million) in a crossover round led by new investor Adage Capital Management. Other new investors included Rock Springs Capital and funds associated with T. Rowe Price...